Definium Therapeutics, Inc. - Common Shares (DFTX)

Last Price21.42

Change+0.40 (1.90%)

NASDAQ · Last Trade: Apr 9th, 5:12 PM EDT

This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.

Via The Motley Fool · March 18, 2026

Definium (DFTX) Q4 2025 Earnings Call Transcript

Via The Motley Fool · February 27, 2026